	Time and Motion Study to Quantify Time for Tysabri (Natalizumab) Intravenous Versus Subcutaneous to Treat Relapsing-Remitting Multiple Sclerosis in France, Spain, and the United Kingdom. Neurol Ther De Cock E, Jomaa K, Menon J, Acosta C, Esquejo-Leon R, Oliver-Smith P. PMID: 41691138 [PubMed - as supplied by publisher]
	Efficacy of traditional swallowing therapy plus neuromuscular electrostimulation in multiple sclerosis: A randomized controlled trial. Mult Scler Relat Disord Grasso MG, Brichetto G, Rovaris M, Beccari R, Cattaneo D, Cuccaro A, Giovanni RD, De Santi S, Fusari G, Giudice C, Grange E, Inglese K, Martinelli D, Monti E, Bragadin MM, Zoli FM, Musto G, Presicce G, Servetto A, Simonelli M, Toscano A, Tufaro A, Vitali C, Tassorelli C, Solaro C. PMID: 41689908 [PubMed - as supplied by publisher]
	Microglia-associated progression of multiple sclerosis: target identification and therapeutic engagement in human in vitro models. Exp Mol Med Blenkle A, Geladaris A, Weber MS. PMID: 41688741 [PubMed - as supplied by publisher]
	Association of anti-inflammatory microglia interleukins with clinical and radiological parameters in patients with multiple sclerosis - a single-centre study in a Polish population. Mol Immunol Mado H, Stasiniewicz A, Nafalska N, Stopyra M, Furgo, Jezierza, Kisielewska W, Kubicka-B, Niedziela N, Sowa P, Adamczyk-Sowa M. PMID: 41687557 [PubMed - as supplied by publisher]
	The 2024 McDonald Criteria for Diagnosis of Multiple Sclerosis: The Rubber Meets the Road. Neurology Miller AE. PMID: 41687050 [PubMed - in process]
	Performance of the 2024 McDonald Criteria in Patients Under Evaluation for Suspected Multiple Sclerosis. Neurology Brownlee WJ, Maccarrone D, Nistri R, Yam C, Wilson H, Wright S, Mankad K, Hemingway C, Thompson AJ, Hacohen Y, Toosy AT, Ciccarelli O. PMID: 41687049 [PubMed - indexed for MEDLINE]
	Housing needs for people with multiple sclerosis: a rapid review. Disabil Rehabil Assist Technol McDonald S, Cubis L, Winkler D, Rothman R, Carey F, Arnold J, Skewes K, Douglas J. PMID: 41686920 [PubMed - indexed for MEDLINE]
	Rapid Estimation of Myelin for Diagnostic Imaging and Quantification of Therapy Responses in Multiple Sclerosis. J Neuroimaging Katsarogiannis E, Ouellette R, Virhammar J, Landtblom AM, Burman J, Granberg T, Berntsson SG. PMID: 41685971 [PubMed - indexed for MEDLINE]
	Safety and efficacy of B-cell therapy in older people with multiple sclerosis. Front Immunol Montague T, Kang Y, Thomas K, Burke Simpson N, Miller C, Chatterton S, Fontes Villalba A, Parratt J. PMID: 41684540 [PubMed - indexed for MEDLINE]
	Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Differential Biomarkers of Response to Dimethyl Fumarate and Ocrelizumab in Multiple Sclerosis. Int J Mol Sci Mingione A, Corona A, Monzani C, Zollo A, Cirocco C, Zaccone T, Scavone M, Podda GM, Signorelli P, Miozzo M, Priori A, Martinelli-Boneschi F. PMID: 41683864 [PubMed - indexed for MEDLINE]
	Innate lymphoid cells: unsung heroes or villains in multiple sclerosis pathogenesis? Immunol Res Aliyu M, Saboor-Yaraghi AA, Sahraian MA, Noorbakhsh F, Adamu AY, Sharif AA, Abdulqadir ZA. PMID: 41680537 [PubMed - indexed for MEDLINE]
	Deep learning-based diagnostic classification of multiple sclerosis using multicenter optical coherence tomography data. Exp Eye Res Khodabandeh Z, Rabbani H, Shirani Bidabadi N, Ashtari F, Steel DH, Bacardit J, Hurlbert A, Kafieh R. PMID: 41679586 [PubMed - as supplied by publisher]
	Transcutaneous electrical nerve stimulation improves walking in fatigued persons with multiple sclerosis: A randomized controlled trial. Ann Phys Rehabil Med Dreijer N, Maffei LB, Veldman MP, Simmelink EK, Heersema DJ, Meilof JF, Zijdewind I. PMID: 41679238 [PubMed - as supplied by publisher]
	Effects of respiratory muscle training on respiratory function, exercise capacity and quality of life in people with multiple sclerosis: a systematic review and meta-analysis. Mult Scler Relat Disord Chen Y, Meng K, Xiang X, Jiang G, Liu Y, Yi Q. PMID: 41678965 [PubMed - as supplied by publisher]
	Persons With Multiple Sclerosis Reveal Distinct Kynurenine Pathway Metabolite Patterns: A Multinational Cross-Sectional Study. Neurol Neuroimmunol Neuroinflamm Kupjetz M, Langeskov-Christensen M, Riemenschneider M, Inerle S, Ligges U, Gaemelke T, Patt N, Bansi J, Gonzenbach RR, Reuter M, Rosenberger F, Meyer T, McCann A, Ueland PM, Eskildsen SF, Emil Nygaard MK, Joisten N, Hvid L, Dalgas U, Zimmer P. PMID: 41678771 [PubMed - in process]
	Whole-brain in situ postmortem MR imaging using a combination of sequences for cortical lesion detection in multiple sclerosis. Radiol Med Bouman PM, Geurts JJG, Jonkman LE, Schoonheim MM, Barkhof F, Haider L. PMID: 41678090 [PubMed - as supplied by publisher]
	Integrated long-term safety of 10-year ozanimod treatment: results from clinical trials in patients with moderate-to-severe ulcerative colitis or relapsing multiple sclerosis. Inflamm Bowel Dis Rubin DT, Danese S, Nakase H, Ungaro RC, Wolf DC, Alekseeva O, Petersen A, Liu Z, Mehra D, Jain A, Osterman MT, Krakovich A, Riolo JV, DeBoer E, Appio J, Sinh P, Cree BAC, Cohen JA, Irving P. PMID: 41677183 [PubMed - as supplied by publisher]
	Gut Microbiota-Derived Metabolites Regulate CASP3 and Neuroimmune Pathways in Multiple Sclerosis: An Integrative Multiomics Study. Mediators Inflamm Li Li, Liu H, Ye Z, Xu W. PMID: 41674923 [PubMed - indexed for MEDLINE]
	Effects of exercise training among adults with multiple sclerosis: protocol for a systematic review that informs an updated prescriptive guideline. Syst Rev Declerck L, Ginis KM, Cheung AL, Jeng B, Zheng P, Huynh TLT, Brunskill A, Motl RW. PMID: 41673923 [PubMed - as supplied by publisher]
	Refining predictors of long-term NEDA-3 status in relapsing-remitting multiple sclerosis: insights from real-world data. Neurol Sci Guerra T, Bianco A, Esposto C, Intini D, Amati F, Guglielmini G, Caputo F, Paolicelli D, Iaffaldano P. PMID: 41673313 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 43323

Page 1 of 2167



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy